Accutane Prescriptions Would Be Limited To Approved Indication Under House Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Legislation from Reps. Stupak and Smith calls for mandatory registry for all Accutane users, prescribers and dispensers. The bill is based upon Roche's latest proposed risk management plan but adds some consumer protection provisions, such as an informed consent requirement for all patients.
You may also be interested in...
Accutane Legislation Planned; Rep. Stupak Wants Mandatory Registries
The registry would require participation of all patients, prescribers, and dispensers of isotretinoin. Stupak calls into question the ability of Roche and FDA to manage such a registry.
Natrecor Use Should Be Limited, Independent Panel Convened By J&J Says
The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.
CMS Has “Very Robust” Number Of Medicare Part D Bids, McClellan Says
Following the June 6 bid submission deadline, CMS expects to have multiple drug plans in every region. Administrator McClellan declines to provide exact number of Part D bids.